Unique technology for antibody sequencing and discovery

Our technologies are built on decades of experience in bioinformatics algorithm and software development. We take pride in offering unique solutions to challenging problems in biology.

Alicanto®

A better way to discover antibodies.

Alicanto® is Digital Proteomics’ novel antibody discovery platform that identifies target-specific antibodies from serum. Our unique technology selects high affinity antibodies without requiring time-consuming and inefficient cell selection, fusions, or cloning. Alicanto® can be applied to discover monoclonal antibodies from rabbits, llamas, goats, and humans.

Jump to:
– Single domain antibody discovery
– Rabbit monoclonal antibody discovery
– Human monoclonal antibody discovery

Read more

Alicanto technology antibody discovery

ValensTM

Resurrect your monoclonal antibody using proteomic de novo sequencing.

ValensTM uses proprietary technology to sequence monoclonal antibodies when the source cell has been lost. When no source DNA/RNA is available, ValensTM uses proteomics technologies to determine the full-length amino acid sequence of a monoclonal antibody. We’ve successfully applied our approach to antibodies from multiple species, including mouse, rat, human, and hamster, and multiple isotypes, including IgG’s and IgM’s. ValensTM can also be used to sequence antibody fragments.

Jump to:
– De novo antibody sequencing
– Protein sequence confirmation

Read more

Valens technology monoclonal antibody sequencing

Reptor

Antibody repertoire sequencing and analysis.

The adaptive immune response to challenge consists of a dynamic and diverse population of B- and T-lymphocytes. Reptor simplifies the interrogation of these populations by combining next-generation sequencing with repertoire analysis, all accessible on the cloud. From tracking individual clones across time to repertoire-wide comparisons across individuals, our Reptor technology provides an intuitive window into the immune repertoires of humans, llamas, alpacas, rabbits, and goats.

Jump to:
– Bulk antibody repertoire sequencing and analysis
– High-throughput hybridoma sequencing


Read more

Reptor technology antibody repertoire sequencing

Quorum Cloud®

Visualize and analyze structurally similar compounds.

98% of spectra in untargeted metabolomics experiments remain unidentified. This translates to missed insights in your research. Quorum Cloud® organizes unidentified spectra into families of structurally-related compounds using molecular networking, enabling the expansion of identifications to family members. Our Quorum Cloud® technology highlights differentially expressed compounds, so you can quickly focus on the compounds that matter.

Read more

Quorum Cloud technology untargeted metabolomics

Never miss new case studies, posters, and other news by subscribing to our newsletter.